SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-235338
Filing Date
2020-08-31
Accepted
2020-08-31 06:47:54
Documents
2
Group Members
NESTLE S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d61604dsc13da.htm SC 13D/A 91643
2 EX-99.1 d61604dex991.htm EX-99.1 3743
  Complete submission text file 0001193125-20-235338.txt   97008
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Subject) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88972 | Film No.: 201149739
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVENUE NESTLE 55 VEVEY V8 CH-1800
Business Address AVENUE NESTLE 55 VEVEY V8 CH-1800 41-21-924-1111
Societe des Produits Nestle S.A. (Filed by) CIK: 0001803539 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A